Drugmaker presents data on new Alzheimer's drug

The company that makes aducanumab for Alzheimer's disease says that the drug slows mental decline. Biogen Inc. revealed its new analyses of data from its phase 3 clinical trials at the Clinical Trials on Alzheimer's Disease conference in San Diego. Biogen had discontinued two clinical trials for the drug in March, but reversed the decision in?October. That's when it [...]
Source: News from Mayo Clinic - Category: Databases & Libraries Source Type: news